Why is Trident Texofab falling/rising?

As of 09-Oct, Trident Texofab Ltd is experiencing a price increase, currently at Rs 350.00, reflecting a rise of Rs 6.1 or 1.77%. The stock has shown strong performance, with a 1-week return of 5.44% and a remarkable 1-month return of 35.14%. It is also trading close to its 52-week high, just 1.14% away from Rs 354. Despite this positive movement, there has been a notable decline in investor participation, with delivery volume dropping by 71.69% compared to the 5-day average. The stock is trading above all key moving averages, indicating a bullish trend, although the absence of specific positive or negative factors makes it difficult to assess any additional influences on its recent movement.
In the broader market context, Trident Texofab's short-term performance significantly outpaces the benchmark Sensex, which has only gained 1.47% over the same week. This strong relative performance suggests that investor sentiment towards Trident Texofab is particularly favorable compared to the overall market. The stock's year-to-date return of 108.09% and 1-year return of 635.91% further highlight its exceptional growth trajectory, contrasting sharply with the Sensex's more modest gains of 5.16% and 0.87%, respectively. This disparity in performance underscores the stock's strong appeal among investors, despite the recent drop in trading volume.